Literature DB >> 11737531

How to validate clinically important change in health-related functional status. Is the magnitude of the effect size consistently related to magnitude of change as indicated by a global question rating?

B Middel1, R Stewart, J Bouma, E van Sonderen, W J van den Heuvel.   

Abstract

Some clinical trials perform repeated measurement over time and estimate clinically relevant change in an instrument's score with global ratings of perceived change or so-called transition questions. The conceptual and methodological difficulties in estimating the magnitude of clinically relevant change over time in health-related functional status (HRFS) are discussed. This paper investigates the concordance between the amount of serially assessed change with effect size estimates (the researcher's perspective) and global ratings of perceived change (the patient's perspective). A total of 217 patients who were scheduled for diagnostic examination were included, and the Minnesota Living with Heart Failure Questionnaire, extended with MOS-20 items, was assessed before and after medical intervention (percutaneous transluminal coronary angioplasty, coronary artery bypass grafting or pharmaco-therapy). Global questions were applied to assess perceived change over time for every item from domains of physical and emotional functioning and used as the external criterion of relevant change in the analysis of items. Global questions corresponding with overall change in these domains were used in the comparison of change in physical and emotional functioning scales. Two effect size indices were used: (i) ES (mean change/SDpooled) and (ii) ES (mean change/SDchange). A method is described to calculate a value indicating the extent of discordance between the researcher's interpretation of magnitude of change and the external criterion (the patient's perspective). Findings suggest that effect size (ES) (mean change/SDpooled) was in keeping with the magnitude of change indicated by patients' judgements, or their category of subjective meaning, for all scales. Furthermore, in cases in which the magnitude of change estimated with the SRM (mean change/SDchange) was not confirmed empirically by the external criterion ratings, the discordance could be interpreted as a trivial discordance.

Entities:  

Mesh:

Year:  2001        PMID: 11737531     DOI: 10.1046/j.1365-2753.2001.00298.x

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  23 in total

1.  Quality of life in adolescents with mild asthma.

Authors:  Teal S Hallstrand; J Randall Curtis; Moira L Aitken; Sean D Sullivan
Journal:  Pediatr Pulmonol       Date:  2003-12

2.  Gender-related needs and preferences in cancer care indicate the need for an individualized approach to cancer patients.

Authors:  Hester Wessels; Alexander de Graeff; Klaske Wynia; Miriam de Heus; Cas L J J Kruitwagen; Gerda T G J Woltjer; Saskia C C M Teunissen; Emile E Voest
Journal:  Oncologist       Date:  2010-05-27

3.  The quality of life of parents of children with atopic dermatitis: interpretation of PIQoL-AD scores.

Authors:  D M Meads; S P McKenna; K Kahler
Journal:  Qual Life Res       Date:  2005-12       Impact factor: 4.147

4.  Burnout among Dutch medical residents.

Authors:  J T Prins; J E H M Hoekstra-Weebers; H B M van de Wiel; S M Gazendam-Donofrio; F Sprangers; F C A Jaspers; F M M A van der Heijden
Journal:  Int J Behav Med       Date:  2007

5.  Ergonomic assessment of neck posture in the minimally invasive surgery suite during laparoscopic cholecystectomy.

Authors:  M J van Det; W J H J Meijerink; C Hoff; M A van Veelen; J P E N Pierie
Journal:  Surg Endosc       Date:  2008-07-12       Impact factor: 4.584

6.  The effect of OPC Factor on energy levels in healthy adults ages 45-65: a phase IIb randomized controlled trial.

Authors:  Patrick J LaRiccia; John T Farrar; Mary D Sammel; Joseph J Gallo
Journal:  J Altern Complement Med       Date:  2008-07       Impact factor: 2.579

7.  Zolpidem extended-release 12.5 mg associated with improvements in work performance in a 6-month randomized, placebo-controlled trial.

Authors:  Milton Erman; Alice Guiraud; Vijay N Joish; Debra Lerner
Journal:  Sleep       Date:  2008-10       Impact factor: 5.849

8.  Design of a Randomised Controlled Trial (RCT) on the effectiveness of a Dutch patient advocacy case management intervention among severely disabled Multiple Sclerosis patients.

Authors:  Klaske Wynia; Coby Annema; Hans Nissen; Jacques De Keyser; Berrie Middel
Journal:  BMC Health Serv Res       Date:  2010-05-27       Impact factor: 2.655

9.  Are health care professionals able to judge cancer patients' health care preferences correctly? A cross-sectional study.

Authors:  Hester Wessels; Alexander de Graeff; Klaske Wynia; Miriam de Heus; Cas L J J Kruitwagen; Saskia C C M Teunissen; Emile E Voest
Journal:  BMC Health Serv Res       Date:  2010-07-08       Impact factor: 2.655

10.  A multicenter, randomized, open-labeled, parallel group trial of sildenafil in alcohol-associated erectile dysfunction: the impact on psychosocial outcomes.

Authors:  Alexander M Ponizovsky; Lev Averbuch; Ira Radomislensky; Alexander Grinshpoon
Journal:  Int J Environ Res Public Health       Date:  2009-09-23       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.